General Information of This Drug (ID: DMEYNQA)

Drug Name
ALN-RSV01   DMEYNQA
Drug Type
siRNA drug

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Respiratory syncytial virus infection DIS7FWHY 1C80 Phase 2 [1]
Respiratory infection DISJE8CF CA07-CA4Z Phase 2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT00658086) Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV). U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT00658086) Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV). U.S. National Institutes of Health.